Drugs / ChAd155-RG
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04019444 | Sep 2019 → Mar 2023 | rabies | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | ChAd155-RG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04019444 ↗ |
| Route | Intramuscular | “ChAd155-RG vaccine administered intramuscularly” NCT04019444 ↗ |